Department of Pharmacy, Methodist University Hospital, 1265 Union Avenue, Memphis, TN, 38104, USA.
Department of Clinical Pharmacy, University of Tennessee Health Sciences Center, 881 Madison Avenue, Memphis, TN, 38104, USA.
Neurocrit Care. 2018 Jun;28(3):344-352. doi: 10.1007/s12028-017-0488-2.
Current guidelines recommend that rapid systolic blood pressure (SBP) lowering to 140 mmHg may be considered in intracerebral hemorrhage (ICH) patients regardless of initial SBP. However, limited safety data exist in patients presenting with varying degrees of severe hypertension. The purpose of this study was to determine whether there was an increased risk of acute kidney injury (AKI) based upon degree of presentation hypertension in ICH patients whose blood pressure was reduced intensively.
This retrospective, cohort study evaluated ICH patients treated with intensive blood pressure control (SBP ≤140 mmHg) who presented with three degrees of presentation hypertension: mild (SBP 141-179 mmHg), moderate (SBP 180-219 mmHg), and severe (SBP ≥ 220 mmHg). Univariate analysis of demographics variables, ICH severity, and factors known to impact AKI was conducted between the three groups. Post hoc testing was used to compare differences between specific groups, with a Bonferroni correction adjusting for multiple comparisons. Additionally, we conducted logistic regression analysis to determine whether baseline SBP group independently predicted AKI.
We included 401 patients (177 with mild, 124 with moderate, and 100 with severe hypertension). There was a significant increase in the prevalence of AKI between groups, with the severe group experiencing the highest rate (p < 0.001). The presence of severe hypertension was also found to independently predict AKI development (odds ratio 2.6; p < 0.001).
Our study observed higher rates of AKI in patients presenting with severe hypertension. Further research is needed to determine the most appropriate strategies for managing blood pressure in ICH patients presenting with higher SBP.
目前的指南建议,无论初始收缩压(SBP)如何,脑出血(ICH)患者可能需要将快速 SBP 降低至 140mmHg。然而,在出现不同程度严重高血压的患者中,安全性数据有限。本研究的目的是确定在血压强化降低的 ICH 患者中,根据其就诊时高血压的程度,是否会增加急性肾损伤(AKI)的风险。
本回顾性队列研究评估了接受强化血压控制(SBP≤140mmHg)治疗的 ICH 患者,这些患者就诊时患有三种程度的高血压:轻度(SBP 141-179mmHg)、中度(SBP 180-219mmHg)和重度(SBP≥220mmHg)。对三组之间的人口统计学变量、ICH 严重程度和已知影响 AKI 的因素进行了单因素分析。使用事后检验比较特定组之间的差异,并使用 Bonferroni 校正进行多次比较调整。此外,我们进行了逻辑回归分析,以确定基线 SBP 组是否独立预测 AKI。
共纳入 401 例患者(轻度 177 例、中度 124 例、重度 100 例)。三组之间 AKI 的患病率存在显著差异,重度组发生率最高(p<0.001)。重度高血压的存在也被发现独立预测 AKI 的发生(优势比 2.6;p<0.001)。
我们的研究观察到重度高血压患者 AKI 发生率较高。需要进一步研究以确定管理 SBP 较高的 ICH 患者血压的最佳策略。